Not applicableWithdrawnNCT03972111What this trial is testingA Phase 4, Observational Field Study to Evaluate TPOXX in Patients With SmallpoxWho this might be right forSmallpox SIGA Technologies
Testing effectiveness (Phase 2)Study completedNCT01827371What this trial is testingPhase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®Who this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID) 435
Large-scale testing (Phase 3)Study completedNCT05846243What this trial is testingStudy on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 YearsWho this might be right forSmallpoxMonkeypoxCowpox+1 more Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 334
Large-scale testing (Phase 3)Study completedNCT00607243What this trial is testingSafety and Efficacy of CJ-50300 in Healthy VolunteersWho this might be right forSmallpox Seoul National University Hospital 123
Large-scale testing (Phase 3)Study completedNCT03699124What this trial is testingFreeze-Dried MVA-BN® Lot Consistency Smallpox TrialWho this might be right forSmallpox Bavarian Nordic 1,129
Testing effectiveness (Phase 2)Study completedNCT00879762What this trial is testingHigh Dose IMVAMUNE® in Vaccinia-Naive IndividualsWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID) 91
Testing effectiveness (Phase 2)Study completedNCT00032708What this trial is testingDryvax Dilution-Prev Vacc AdultsWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Looking for participantsNCT07377175What this trial is testingStudy to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.Who this might be right forSmallpoxCowpoxMonkeypox+1 more China National Biotec Group Company Limited 76
Testing effectiveness (Phase 2)Study completedNCT00026611What this trial is testingDryvax Vaccine Against Smallpox in Previously Unvaccinated AdultsWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00046397What this trial is testingPhase I Trial of Smallpox VaccineWho this might be right forHealthy National Institute of Allergy and Infectious Diseases (NIAID) 195
Early research (Phase 1)Study completedNCT00053742What this trial is testingPhase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against SmallpoxWho this might be right forHealthy National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT00123396What this trial is testingVHA Clinicians and Bioterror Events: Interactive Web-based LearningWho this might be right forSmallpoxAnthrax US Department of Veterans Affairs 15
Testing effectiveness (Phase 2)Study completedNCT00050518What this trial is testingAPSV in Vaccinia Naive AdultsWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID) 444
Early research (Phase 1)Study completedNCT00336635What this trial is testingSafety and Immunogenicity of CJ-50300Who this might be right forSmallpox Seoul National University Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00316602What this trial is testingA Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Bavarian Nordic 632
Testing effectiveness (Phase 2)Active Not RecruitingNCT06549530What this trial is testingOpen-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus InfectionsWho this might be right forMonkeypox (Mpox) Bavarian Nordic 460
Early research (Phase 1)WithdrawnNCT00303225What this trial is testingSIGA-246 to Treat SmallpoxWho this might be right forVaccinia National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00063856What this trial is testingDressing Preparations for SmallpoxWho this might be right forSmallpox National Institute of Allergy and Infectious Diseases (NIAID) 102
Early research (Phase 1)Study completedNCT00000767What this trial is testingA Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Looking for participantsNCT07379580What this trial is testingClinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in AfricaWho this might be right forMpox (Monkeypox)SmallpoxOrthopoxvirus Infection BioNTech SE 310